Because CLL cells’ metabolic pathways resembles those of adipocytes [14] and the CD36 gene harbors putative STAT3-binding sites, we hypothesized that STAT3 induces CD36 cell surface expression and that CD36 facilitates FA uptake in CLL cells. The gene discussed is CD36; the disease is B-cell chronic lymphocytic leukemia.